FDA Inspection 1029821 — Valentyna Berezenko, M.D., Ph.D.
The FDA completed an inspection of Valentyna Berezenko, M.D., Ph.D. on Aug 25, 2017 in Kyiv. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 25, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kyiv (Ukraine)
Additional details
Clinical Investigator (CI)